GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ppp2ca | decreases response to substance | EXP | | 6480464 | CTD | PPP2CA protein mutant form results in decreased susceptibility to Okadaic Acid | PMID:29241734 | Ppp2ca | decreases activity | ISO | PPP2CA (Homo sapiens) | 6480464 | CTD | Okadaic Acid results in decreased activity of PPP2CA protein | PMID:15965230 PMID:22205926 | Ppp2ca | multiple interactions | ISO | PPP2CA (Homo sapiens) | 6480464 | CTD | [Okadaic Acid results in decreased activity of PPP2CA protein] which results in decreased susceptibility to Dexamethasone; morroniside inhibits the reaction [Okadaic Acid results in decreased methylation of and results in increased phosphorylation of and results in decreased activity of [PPP2CA protein binds to PPP2CB protein]]; Okadaic Acid inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; Okadaic Acid results in decreased activity of [PPP2CA protein binds to PPP2CB protein]; Okadaic Acid results in decreased methylation of and results in increased phosphorylation of and results in decreased activity of [PPP2CA protein binds to PPP2CB protein] | PMID:21655183 PMID:22205926 PMID:26836014 | Ppp2ca | multiple interactions | ISO | Ppp2ca (Mus musculus) | 6480464 | CTD | [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride co-treated with Memantine] results in increased expression of PPP2CA mRNA; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride co-treated with Memantine] results in increased expression of PPP2CA protein; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in decreased expression of PPP2CA protein; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of PPP2CA mRNA | PMID:33069748 | |
Go Back to source page | Continue to Ontology report |